It can be inferred that these mutational profiles indicate the acquisition of driver mutations and loss of CDKN2A/p16 are the first and major events in very early AIS cases, with other genomic events occurring at later stages. The gene discussed is CDKN2A; the disease is androgen insensitivity syndrome.